Commercial Success

Commercial success is one of the four 'secondary considerations' or 'objective indicia' of non-obviousness established by the Supreme Court in Graham v. John Deere Co. (1966). The rationale: if a claimed invention is commercially successful, that success reflects market recognition that the invention provides something new and valuable — something that a competitor would have introduced earlier if the invention were obvious. UNDERLYING LOGIC: If a product embodying the claimed invention is commercially successful in a competitive market, the market has validated that the invention solves a problem or meets a need in a way that was not obvious to competitors — who would presumably have developed the same solution earlier if it were obvious, and would have captured the same market opportunity. COMMERCIAL SUCCESS IS NOT AUTOMATIC: the mere fact that a product is commercially successful does not automatically create a secondary consideration of non-obviousness; the success must be tied to the specific features of the claimed invention (the nexus requirement) rather than to factors like aggressive marketing, brand recognition, or prior art features that are not part of the claim. RELATIONSHIP TO OTHER SECONDARY CONSIDERATIONS: commercial success is often combined with long-felt need (the problem existed for years), failure of others (prior products didn't succeed), and industry praise (recognition from experts) to build a comprehensive objective indicia argument.

The nexus requirement is the most critical and most often contested element of a commercial success argument. Nexus means that the commercial success of the product must be CAUSALLY LINKED to the PATENTED FEATURES of the claimed invention — not to other factors. THE NEXUS STANDARD: the patent applicant/owner must establish that the commercial success is attributable to the novel and non-obvious features of the claimed invention, as opposed to: (1) features of the product that are in the prior art (and thus do not reflect any inventive contribution); (2) marketing, advertising, or brand positioning; (3) price advantages, supply chain efficiencies, or distribution advantages; (4) regulatory exclusivities (FDA approval, government contracts); (5) first-mover advantages unrelated to the invention's technical merit. PRESUMPTION OF NEXUS: when the commercial embodiment of the product is 'coextensive' with the claimed invention (i.e., all features of the product are claimed), there is a rebuttable presumption of nexus; in this case, the burden shifts to the examiner or challenger to show that the success is due to non-claimed features; J.T. Eaton & Co. v. Atlantic Paste & Glue (Fed. Cir. 1997). NEXUS CHALLENGE IN MULTI-FEATURE PRODUCTS: in products with many features (smartphones, pharmaceuticals), establishing nexus is difficult because success may be attributable to features that are not claimed; isolating the contribution of the patented feature requires market analysis, consumer surveys, and expert testimony.

In USPTO patent prosecution, commercial success is typically established through a Declaration under 37 C.F.R. § 1.132 filed in response to an obviousness rejection. THE DECLARATION SHOULD INCLUDE: (1) SALES DATA — revenue, units sold, market share, and growth rate for the product embodying the claimed invention; compare to industry averages or prior art products if possible; cite specific dollar amounts and time periods; (2) MARKET SHARE — demonstrate that the product has captured substantial market share in a competitive market; (3) LICENSING — evidence that others have sought licenses to the claimed invention (voluntary licenses to sophisticated commercial entities are particularly probative — they paid to use the technology rather than design around); (4) INDUSTRY RECOGNITION — awards, trade press coverage, analyst reports highlighting the innovation as a reason for the product's success; (5) COMPETITOR COPYING — evidence that competitors have copied the specific features claimed in the invention (rather than designing around them) is strong evidence of non-obviousness and nexus; (6) NEXUS EVIDENCE — the declaration must specifically explain how the patented features are responsible for the commercial success; if possible, compare sales of the product with the patented feature vs. prior art products without that feature; (7) DECLARANT — the declaration should be signed by someone with personal knowledge — the patent owner, a business executive with access to financial records, or a market analyst with independent data.

Courts have consistently held that secondary considerations must be considered and given weight — they cannot simply be dismissed as irrelevant. However, the weight given depends on: (1) STRENGTH OF THE PRIMA FACIE CASE: if the primary Graham factors (prior art teachings, differences from prior art, level of POSITA skill) are extremely strong — for example, if the prior art explicitly teaches the exact combination claimed and a POSITA would have been motivated to combine — commercial success may not be enough to overcome the rejection; (2) STRENGTH OF THE NEXUS: a robust, well-documented nexus directly tying the patented feature to the success is much more persuasive than a general assertion that the product sells well; (3) MAGNITUDE OF SUCCESS: dramatic commercial success in a competitive market is more compelling than modest sales improvements; a product that dominates a large, competitive market where prior art products existed is stronger evidence than a niche product; (4) COMBINATION WITH OTHER SECONDARY CONSIDERATIONS: commercial success combined with long-felt need, failure of others, and industry praise creates a more compelling package; no single secondary consideration is typically dispositive. KEY CASES: Stratoflex v. Aeroquip (Fed. Cir. 1983) — commercial success and other secondary considerations must be considered and can tip the balance; Apple v. Samsung — commercial success of iPhone features was part of the non-obviousness analysis; Graham v. John Deere — the Supreme Court first articulated the four-factor test including secondary considerations.

Yes — a commercial success argument can be challenged by pointing to factors other than the patented features that explain the success: (1) PRIOR ART FEATURES — the most common rebuttal is arguing that the success is attributable to features that were already in the prior art, not to the novel aspects of the claimed invention; to survive this challenge, the nexus must specifically identify the INVENTIVE features (those not in the prior art) as the cause of success; (2) MARKETING / BRAND / DISTRIBUTION — success driven by advertising spend, brand loyalty, or distribution advantages does not reflect technical merit of the claimed invention; (3) REGULATORY EXCLUSIVITY — for pharmaceuticals, success may be driven by patent protection itself creating market exclusivity (not by the technical features); this circularity argument — 'success is due to the monopoly granted by the patent, not by the technical merit' — has been accepted in some contexts; (4) MARKET CONDITIONS — a product may succeed in a growing market regardless of its technical features; (5) BLOCKING EFFECT — if the patent owner is the only entity allowed to make the product due to the patent, others cannot offer competing products regardless of the obviousness of the invention — reducing the evidentiary value of commercial success. KEY CASE: Ormco Corp. v. Align Technology (Fed. Cir. 2008) — the court held that a nexus presumption may be rebutted by showing the success is attributable to features that are not novel.